Skip to main content

Advertisement

SpringerLink
Log in

The world’s first clinical trial for an aplastic anemia patient with thrombocytopenia administering platelets generated from autologous iPS cells

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nature Editorials. Racing hearts. Japan must show that a promising therapy for damaged hearts works as claimed. Week Nat. 2018;557:611–2.

    Google Scholar 

  2. Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M, et al. Turbulence activates platelet biogenesis to enable clinical scale ex vivo production. Cell 2018;174(3):636–48. https://doi.org/10.1016/j.cell.2018.06.011 (Epub 2018 Jul 12).

    Article  CAS  PubMed  Google Scholar 

  3. Akabayashi A, Nakazawa E, Jecker NS. Tighten up clinical trial of stem cells. Nature. 2018;560:431. https://doi.org/10.1016/j.cell.2018.06.011.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Biomedical Ethics, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan

    Akira Akabayashi & Eisuke Nakazawa

  2. Division of Medical Ethics, Department of Population Health, New York University School of Medicine, New York, NY, 10016, USA

    Akira Akabayashi

  3. Department of Bioethics and Humanities, University of Washington School of Medicine, Seattle, WA, 98195-7120, USA

    Nancy S. Jecker

  4. African Centre for Epistemology and Philosophy of Science, University of Johannesburg, Johannesburg, South Africa

    Nancy S. Jecker

Authors
  1. Akira Akabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eisuke Nakazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nancy S. Jecker
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AA: conceptualization, writing—original draft, writing—review and editing. EN: conceptualization, formal analysis, writing—review and editing. NJ: conceptualization, writing—review and editing.

Corresponding author

Correspondence to Akira Akabayashi.

Ethics declarations

Conflict of interest

AA is President of the Japan Association for Bioethics; this paper reflects the author’s personal academic analyses and opinions and does not represent JAB’s official position. EN and NSJ have no conflict of interest to declare.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akabayashi, A., Nakazawa, E. & Jecker, N.S. The world’s first clinical trial for an aplastic anemia patient with thrombocytopenia administering platelets generated from autologous iPS cells. Int J Hematol 109, 239–240 (2019). https://doi.org/10.1007/s12185-018-02565-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-018-02565-y

Search

Navigation